The Discounted Cash Flow (DCF) valuation of Moderna Inc (MRNA) is (116.14) USD. With the latest stock price at 24.02 USD, the upside of Moderna Inc based on DCF is -583.5%.
Based on the latest price of 24.02 USD and our DCF valuation, Moderna Inc (MRNA) is a sell. selling MRNA stocks now will result in a potential gain of 583.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.8% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (226.44) - (79.23) | (116.14) |
| Upside | -1042.7% - -429.9% | -583.5% |